Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06161285
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-12
First Post:
2023-11-30
Brief Title:
Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BRONCHOBIOTE
Brief Summary:
Acute bronchiolitis is a common disease in children under the age of two caused mainly by the respiratory syncytial virus RSV Furthermore given the same medical history it is still very difficult to predict the course and severity of the infection at the onset of symptoms Some studies have highlighted the importance of the microbiota intestinal oral or nasopharyngeal and of the immune response to RSV in children We will include 80 children under 2 years old with hospitalized bronchiolitis and non-hospitalized bronchiolitis Oral nasal and stool samples will be taken to study the various microbiota in search of dysbiosis A capillary blood sample will be taken for immune studies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2023-A01688-37 | OTHER | IDRCB | None |